Press Release Archive - Corporate News

Corporate News

09.27.2012
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
08.30.2012
IRONWOOD AND FOREST ANNOUNCE FDA APPROVAL OF LINZESS(TM) (LINACLOTIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION AND CHRONIC IDIOPATHIC CONSTIPATION
08.30.2012
IRONWOOD AND FOREST TO HOST CONFERENCE CALL TO DISCUSS FDA APPROVAL OF LINZESS(TM) (LINACLOTIDE) FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH CONSTIPATION AND CHRONIC IDIOPATHIC CONSTIPATION
08.27.2012
Forest Laboratories Adopts Stockholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights
08.24.2012
Forest Announces Certified Annual Meeting Results
08.15.2012
Forest Announces Preliminary Results of Annual Meeting of Shareholders
08.13.2012
Forest Laboratories Issues Open Letter to Shareholders
08.10.2012
Forest Laboratories Responds to False and Misleading Statements by Carl Icahn
08.07.2012
Forest Laboratories Sends Letter to Shareholders
08.06.2012
Forest Laboratories to File Investor Presentation and White Paper